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AntioxidantSkeletal muscle is a key organ of mammalian energy metabolism, and its mitochondria are multifunction
organelles that are targets of dietary bioactive compounds. The goal of this work was to examine the regulation
of mitochondrial dynamics, functionality and cell energy parameters using docosahexaenoic acid (DHA),
epigallocatechin gallate (EGCG) and a combination of both in L6myocytes. Compounds (at 25 μM)were incubat-
ed for 4 h. Cells cultured with DHA displayed less oxygen consumption with higher ADP/ATP ratio levels
concomitant with downregulation of Cox and Ant1 gene expression. The disruption of energetic homeostasis
by DHA, increases intracellular reactive oxygen species (ROS) levels and decreases mitochondrial membrane
potential. The defence mechanism to counteract the excess of ROS production was by the upregulation of
Ucp2, Ucp3 and MnSod gene expression. Moreover myocytes cultured with DHA had a higher mitochondrial
mass with a higher proportion of large and elongated mitochondria, whereas the ﬁssion genes Drp1 and Fiss1
and the fusion geneMfn2 were downregulated. In myocytes co-incubated with DHA and EGCG, ROS levels and
the adenosine diphosphate (ADP)/adenosine triphosphate (ATP) ratio were similar to untreated myocytes and
the decrease of oxygen consumption, higher mitochondrial mass and the overexpression of Ucp2 and Ucp3
genes were similar to the DHA-treated cells with also a higher amount of mitochondrial deoxyribonucleic acid
(DNA), and reduced Drp1 and Fiss1 gene expression levels. In conclusion the addition of EGCG to DHA returned
the cells to the control conditions in terms of mitochondrial morphology, energy and redox status, which were
unbalanced in the DHA-treated myocytes.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are ubiquitous organelles in eukaryotic cells whose
primary functions are to generate energy, regulate the cellular redox
state and calcium homeostasis, and initiate cellular apoptosis [1]. In
addition,mitochondria are themain intracellular source and immediate, adenine nucleotide translocase
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ights reserved.target of reactive oxygen species (ROS), which are continuously
generated as byproducts of aerobic metabolism in mammalian cells.
Thus, mitochondria play a pivotal role in the determination of the life
and death of the mammalian cell [2]. The size, shape, and abundance
of mitochondria vary dramatically in different cell types and may
change under different energy demands and physiological environmen-
tal conditions [3]. In many cell types, especially muscle ﬁbres,
mitochondria form tubular structures or networks [4]. Increasing
evidence, suggests that mitochondrial structure determines mitochon-
drial function [5] including substrate metabolism and mitochondrial
bioenergetics. Mitochondria are highly dynamic organelles with
constant fusion and ﬁssion events mediated by conserved cellular
machineries. The frequencies of these fusion and ﬁssion events are
balanced to maintain the overall morphology of the mitochondrial
population [6] and to control mitochondrial energy metabolism,
protecting cells from mitochondrial damage and maintain the overall
architecture of these organelles [7,8].
Mitochondria are recognised as major targets of bioactive
compounds, such as omega-3 polyunsaturated fatty acids (PUFAs)
and ﬂavonoids, which are found in healthy diets. The current data
support a role for omega-3 PUFA supplementation, particularly
docosahexaenoic acid (DHA),which is strongly associatedwith changes
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organisational domains [9–14]. Although DHA is a likely target
for oxidation [15–17], its health beneﬁts are largely derived through
DHA (22:6n − 3) rapidly in place of other fatty acids into
biological membranes, particularly plasma and mitochondrial mem-
branes and its cell signalling mechanisms. Incorporation of 22:6n− 3
inﬂuences membrane structure and function [18], increasing
membrane permeability [19] ﬂuidity and plasticity altering conforma-
tional states with their acyl chains, which are extremely ﬂexible [13],
and inﬂuences the physical properties of biologicalmembranes, thereby
altering protein function and fusion [13,20]. In addition to being suscep-
tible to lipid peroxidation, DHA could decrease mitochondrial function
simply as a result of the accumulation of oxidised products [21], altering
the lipid bilayer and decreasing bioenergetic activities due tomembrane
perturbations [19]. In mitochondria, PUFAs play a role in several
mitochondrial processes, includingmitochondrial calcium homeostasis,
gene expression, and respiratory function, and act as protonophores to
reduce mitochondrial ROS production through uncoupling protein
(UCP)-mediated decreases in mitochondrial membrane potential [17].
Mitochondria can also be regarded as important intracellular targets
of agents that protect from the undesirable action of ROS, such as poly-
phenols, which prevent against many pathological states involving oxi-
dative cell damage [22]. Epigallocatechin-3-gallate (EGCG) is the most
abundant polyphenol isolated from green tea and is widely studied
because it promotes cardiovascular and metabolic health by acting as
a potent antioxidant that may have therapeutic applications in the
treatment of many disorders. EGCG has antioxidant properties [23–25]
with powerful radical scavengers. These antioxidant activities are due
to the presence of phenolic groups that are sensitive to oxidation and
are increased by the presence of the trihydroxyl structure in the D
ring of EGCG [26]. Therefore, the presence of antioxidants jointly with
omega-3 PUFAswould prevent possible oxidative deterioration. Despite
the beneﬁcial response of EGCG and DHA in muscle cells, here, we
tested the hypothesis that EGCG has protective effects on the DHA
oxidation, associated to the changes of physical properties of biological
membranes and consequent changes in energymetabolism due to DHA
intake. Taking into account that skeletal muscle tissue is a major
determinant of whole-body energy metabolism, the aim of this study
was to examine how EGCG and DHA, alone or in combination, affect
cell energy homeostasis, mitochondrial functionality and morphology,
oxidative phosphorylation, ROS generation and calcium homeostasis
in L6 myocytes.
2. Materials and methods
2.1. Chemicals
(−) Epigallocatechin-3-gallate (EGCG) from green tea, cis-
4,7,10,13,16,19-docosahexaenoic acid (DHA), fatty acid-free BSA, 2′,7′-
dichloroﬂuorescin diacetate (DCFH-DA), DMSO, Bradford reagent,
carbonyl cyanide 4-(triﬂuoromethoxy)phenylhydrazone (FCCP),
oligomycin, rotenone, antimycin A, rhodamine 123 (Rhd123), ethanol,
succinate and Fluo-3 acetoxymethyl ester (Fluo-3 AM) were obtained
from Sigma-Aldrich (Madrid, Spain), and the MitoTracker FM was
obtained from Molecular Probes (Eugene, Oregon, USA). Dulbecco's
modiﬁed Eagle's medium (DMEM), glutamine, fetal bovine serum
(FBS), penicillin and streptomycin were obtained from BioWhittaker
(Verviers, Belgium).
2.2. Cell culture
L6 myocyte cells (kindly supplied from Dr. Manuel Portero-Otín)
were routinely cultivated in DMEM supplemented with 2 mM
glutamine, 10% FBS, 1% penicillin (126.6 U/mL) and 1% streptomycin
(0.126 mg/mL) at 37 °C in an atmosphere of 5% CO2. The cells
were grown to approximately 80% conﬂuence and then induced todifferentiate into myotubes in DMEM supplemented with 2% FBS.
After 7 days, myotube differentiation was complete, and the experi-
mental procedure was initiated. L6 cells were serum-starved for 4 h be-
fore the assay. All experiments were performed in triplicate in 3
independent experiments.
2.3. Cell treatment
To study the effects of EGCG, DHA and the combination of both com-
pounds on mitochondrial function, metabolism and morphology, L6
myocyte cells were treated with the vehicle control, 25 μM EGCG,
25 μM DHA, or 25 μM EGCG + 25 μM DHA. Both compounds were dis-
solved in ethanol and added to the culture media. The medium used
during the treatmentwas serum-freeDMEM containing 2% BSA. The ex-
periments were performed in triplicate and with 3 different passages.
The ﬁnal concentration of ethanol in the media was 0.05%, a nontoxic
percentage. After 4 h, the cells were used for the different analyses.
2.4. Cell death
Cell death was assessed by lactate dehydrogenase (LDH) leakage
into the culture medium. Following the 24 h of exposure to EGCG and
DHA (25 μM), the culture medium was aspirated and centrifuged at
3000 rpm for 5 min to obtain a cell-free supernatant; on the other
hand cells were lysed in cold buffer (25 mM HEPES pH 7.0, 0.1% Triton
X-100). The next stepswere performed according to themanufacturer's
instructions for the LDH kit (QCA; Amposta, Spain). The % of LDH leak-
age was normalised to control group and calculated as follows:
%LDH leakage ¼ mUmediumð Þ= mU medium mU cellsð Þð Þ  100:
2.5. Oxygen consumption assay in intact cells
In vivo measurements of mitochondrial oxygen consumption with
intact cellswere performed using a high-resolution oxygraph (Oroboros
Instruments, Innsbruck, Austria) to quantify the respiration states. L6
myocytes were treated in 6-well plates and removed from culture
dishes through trypsinisation (0.05% trypsin–EDTA). After 5min of cen-
trifugation at 200 g (room temperature), the cells were resuspended in
warmed respiration medium (DMEM without fetal bovine serum) and
transferred to the corresponding respiration chamber at a concentration
of 4–6 × 106 cells/mL. Analyses of respiration rates were performed in
2 mL of respiration medium at 37 °C with stirring at 750 rpm. When
the oxygen concentrationwas stabilised, basal respirationwas recorded
(Routine state) to control the levels of respiration and phosphorylation
in a physiologically coupled state, which was supported by exogenous
substrates in the culture media. Following stabilisation of the Routine
state, ATP synthesis was inhibited with 2 μg/mL oligomycin, and the
nonphosphorylating or resting state (Leak state) was recorded. Subse-
quently, 10–12 μM FCCP was added to stimulate respiration maximally
at a level ﬂow, measuring the electron transport system (ETS) capacity
in the noncoupled state (ETS state). In sum, respiration was blocked
with 2.5 μM rotenone and 2.5 μM antimycin, representing the residual
oxygen consumption (ROX) state that remains after electron transport
chain (ETC) inhibition. The results are expressed as oxygen ﬂow per
number of cells (pmol oxygen/106 cells ∗ s). All results were corrected
using the ROX state capacity. Oxygen consumption was calculated
using DataGraph Software from Oroboros Instruments (Innsbruck,
Austria).
2.6. Determination of ADP/ATP ratio
The total ADP/ATP ratio in themuscle cells was determined after 4 h
of treatment using the ApoSENSOR™ADP/ATP ratio assay kit (Biovision,
Mountain View, CA, USA) following the manufacturer's instructions.
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The levels of intracellular ROS were quantiﬁed using the ﬂuorescent
probe 2′,7′-dichloroﬂuorescein-diacetate (DCFH-DA) [27]. A stock solu-
tion (10 mM) of DCFH was prepared in DMSO. Cells (2 × 106 per well)
were incubated in black 24-well plates with clear bottoms. DCFH-DA
diffuses into cells and becomes trapped inside the cell after being
cleaved by intracellular esterases.
After treatment, the cells were washed twice with warmed PBS, and
10 μMof DCFH diluted in PBS was then loaded into the wells for 30 min
at 37 °C in the dark. The cells were then gently washed twice in PBS to
remove the excess dye and resuspended in 0.5 mL of PBS per well. The
ﬂuorescence intensity was recorded over 4 h as ameasure of the degree
of cellular oxidative stress. Intracellular ROS production was measured
using an FLx800 Multi-Detection Microplate Reader (BioTek, Winooski,
USA) at an excitation wavelength of 485 nm and an emission wave-
length of 530 nm (37 °C). The measured ﬂuorescence values are
expressed as a percentage of ﬂuorescence with respect to the control
group.2.8. Measurement of mitochondrial membrane potential (MMP)
MMPwasmonitored using Rhd123 dye ﬂuorescence with an excita-
tion wavelength of 525 nm and an emission wavelength of 485 nm
using an FLx800Multi-DetectionMicroplate Reader (BioTek; Winooski,
USA) at 37 °C. Rhd123 is a membrane-permeant cation that is strongly
sequestered inmitochondria due to their negativemembrane potential.
If mitochondria become depolarised, Rhd 123 is redistributed from the
mitochondria to the cytosol, where it becomes diluted and, as a conse-
quence, the ﬂuorescence increases. Therefore, a decrease in ﬂuores-
cence corresponds to an increase in MMP. To perform the analysis,
cells (2 × 106 per well) were incubated in black 24-well plates with
clear bottoms. Rh123 was dissolved in ethanol as a 0.5 mM stock solu-
tion. After treatment, the cells were washed 3 times with warm PBS
and permeated with a permeating solution (0.5 μg/mL digitonin,
250 mM sucrose, 1 mM EDTA, 50 mM KCl, 2 mM KH2PO4, 25 mM
Tris–HCl (pH 7.4)). To initiate the assay, 6 mM of succinate and
0.5 μg/mL Rhd 123 were added to the wells. Fluorescence was recorded
after the addition of 2 μg/mL oligomycin to inhibit the ATP synthase,
and 10 μg/mL of FCCP was then added to visualise the complete
depolarisation. The results are expressed as a % compared to the control
group.2.9. Measurement of intracellular Ca2+ levels
Intracellular Ca2+wasmeasured using the ﬂuorescent calcium indi-
cator Fluo-3 AM. This dye is a fat-soluble reagent, is not ﬂuorescent and
is membrane permeate. Intracellular esterases break down the Fluo-3
AM ester into acetoxymethyl and Fluo-3, which can then combine
with free intracellular calcium ions. The intensity of the ﬂuorescence is
dependent on the free calcium concentration. L6 cells were treated in
24-well black plates with clear bottoms. After treatment, the cells
were washed three times in standard medium (141 mM NaCl, 4.7 mM
KCl, 1.8 mM CaCl2, 1.2 mM MgSO4, 10 mM glucose, 10 mM HEPES
(pH 7.4)). The cells were loaded with Fluo-3 AM (5 μM) for 45 min
(37 °C) in the dark in the standardmedium. The cells were thenwashed
again to allow for the cleavage of the acetoxymethyl esters and resus-
pended in the standard medium or Ca2+-free solution (the same as
the standard medium except for the addition of calcium). Fluorescence
wasmeasured after 30min using an FLx800Multi-DetectionMicroplate
Reader (Biotek, Winooski, USA) with an excitation wavelength of 503
and emission wavelength of 526 (37 °C). The Ca2+ level is expressed
as a percentage of the ﬂuorescence intensity relative to the control
group's ﬂuorescence intensity.2.10. RNA extraction and quantitative real-time PCR (qRT-PCR) analysis
Total RNA was obtained from L6 cells using a RNeasy Mini kit
(Qiagen; Valencia, Spain) according to the manufacturer's protocol.
RNA (4 μg) was reverse transcribed to complementary DNA from the
total RNA using a reverse transcription reagent kit (Applied Biosystems;
Madrid, Spain). Gene expression was analysed by qRT-PCR ampliﬁca-
tion using TaqMan Universal 2× PCR Master Mix (Applied Biosystems;
Madrid, Spain) and a PCR 7300 system (Applied Biosystems; Madrid,
Spain) according to the manufacturer's instructions.
The thermal cycling consisted of an initial step at 50 °C for 2 min,
followed by a polymerase activation step at 95 °C for 10 min and a cy-
cling step with the following conditions: 40 cycles of denaturation at
95 °C for 15 s and annealing at 60 °C for 1 min. Speciﬁc TaqMan
assay-on-demand probes were used to amplify the cDNA: cyclophilin
peptidylprolyl isomerase A (Ppia) (Rn00690933_m1) (used as an en-
dogenous control gene), cytochrome c oxidase subunit V (Cox) (Rn
00821806_m1), citrate synthase (Cs) (Rn00756225_m1), ATP5A1
(ATPase) (Rn01527025_m1), adenine nucleotide translocase 1 (Ant1)
(Rn 00821477_g1), uncoupling protein 3 (Ucp3) (Rn00565874_m1),
uncoupling protein 2 (Ucp2) (Rn00571166_m1), manganese superox-
ide dismutase (MnSod) (Rn00566942_g1), mitochondrial ﬁssion 1 pro-
tein (Fiss1) (Rn01480911_m1), dynamin-related protein 1 (Drp1)
(Rn00586466_m1), mitofusin 2, (Mfn2) (Rn00500120_m1), and optic
atrophy 1 (Rn_00592200_m1) (Opa1). The expression levels were nor-
malised to cyclophilin using a comparative (2−ΔΔCt) method.
2.11. Measurement of mtDNA/nDNA ratio
Total DNA was extracted from cells using a Qiamp DNA mini kit
(Qiagen; Valencia, Spain) according to the manufacturer's instructions.
The relative mitochondrial DNA (mtDNA) levels were measured by
real-time PCR using the PCR 7300 system (Applied Biosystems,
Madrid, Spain) and normalised by simultaneous measurement of the
nuclear DNA (nDNA), (mtDNA/nDNA ratio). Primers and probes for
quantitative PCR (qPCR) were designed using Primer Express (Applied
Biosystems, Madrid, Spain): Nd3 mitochondrial gene (forward: 5′-
cttatcttttatcctcatttcaattgca-3′, reverse: 5′-gtagtgggtattggttgtttgaatc
gctc-3′) and Gapdh as a nuclear gene (forward: 5′-ccagaacatcatccctg
cat-3′; reverse: 5′-gttcagctctgggatgacctt-3′).
PCR conditionswere 95 °C for 15min, followed by 40 cycles of 95 °C
for 15 s, and 60 °C for 60 s. The threshold cycle number (Ct) values formi-
tochondrial NADH-dehydrogenase subunit 3 (Nd3) and glyceraldehydes-
3-phosphate dehydrogenase (Gapdh) were determined. The results were
calculated from the difference in threshold cycle (ΔCt) values for mtDNA
and nuclear-speciﬁc ampliﬁcation.
2.12. Measurement of mitochondrial morphology
To determine the mitochondrial morphology of individual cells, L6
myocytes were grown on coverslips inside 6-well collagen-treated
plates ﬁlled with the appropriate culture medium. After treatment, the
media was removed from the dish, and the cells were washed 3 times
with prewarmed PBS. The cells were stained and incubated at 37 °C
for 30 min with 400 nM MitoTracker Green FM. After staining cells
were washed twice in PBS. The solution was then replaced with fresh
media, and the cells were coverslipped for ﬂuorescence microscopy to
examine their morphology. Confocal imageswere obtained using a con-
focal laser-scanning microscope (NIKON TE-2000; Tokyo, Japan) with a
60× objective. MitoTracker Green FM preferentially accumulates in mi-
tochondria regardless of the mitochondrial membrane potential and
provides an accurate assessment of mitochondrial mass. For the quanti-
ﬁcation of mitochondrial morphology, mitochondrial length was
measured and grouped into three categories as follows: short type
(1 μm ≤ in length), medium rod type (1–2 μm in length) and long
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of the total number mitochondria counted per treatment.
2.13. Statistical analyses
The results are expressed as the mean ± SEM of 6 animals. SPSS
Statistics version 19 software (SPSS Inc., Chicago, IL, USA) was used for
statistical analyses. Signiﬁcant differences were analysed using one-
way analysis of variance (ANOVA) followed by Tukey's post-hoc test.
A p-value ≤ 0.05 was considered statistically signiﬁcant.
3. Results
3.1. DHA increases the ADP/ATP ratio in addition to lowering oxygen
consumption in intact L6 cells even when combined with EGCG
Cell death did not change when cells were treated with the selected
physiological concentration of 25 μM for EGCG and DHA, as assessed by
% LDH leakage (Fig. 1). Fig. 2 presents the changes in respiration caused
by the different treatments in Routine, Leak and ETS states. The Routine
state (Fig. 2a) controls physiological respiration through the cellular en-
ergy demand and is supported by the substrates in the culture media.
Here, in the Routine state, despite neither EGCG nor DHA modiﬁed cell
viability, treatment with DHA or DHA + EGCG for 4 h signiﬁcantly
reduced the oxygen consumption of the L6 cells, whereas there were
no signiﬁcant differences in oxygen consumption between the EGCG
and control groups. By measuring the respiration rate in the presence
of oligomycin, an ATPase inhibitor that is a direct measure of uncoupled
respiration (Leak state) in situ (Fig. 2b), it has been shown that in the
DHA and EGCG + DHA groups, oxygen consumption was signiﬁcantly
decreased. In addition in the ETS state (Fig. 2c), in the presence of
FCCP, an uncoupler to measure the maximal respiratory capacity, a
decrease in the DHA and EGCG+ DHA groups compared to the control
and EGCG groups was evident, though not statistically signiﬁcant.
Fig. 2d presents a representative trace for the oxygen concentration
in the chamber. This chart shows the differences between the groups inFig. 1. % LDH leakage of L6 cells under different concentrations of EGCG and DHA.
Cells were incubated with increasing concentrations (5 μM, 10 μM, 15 μM, 25 μM,
50 μM, 75 μM) of epigallocatechin-3-gallate (EGCG) or docosahexaenoic acid (DHA) for
24 h and cell death was assessed by the lactate dehydrogenase (LDH) method. The
results are expressed in % LDH Leakage normalised to the control group and represent
themean ± SEM of triplicate measurements and are representative of three independent
experiments. Different letters indicate statistical signiﬁcance (p ≤ 0.05).terms of the oxygen consumed in the different states and dependent on
the treatment used. It clearly indicates that theDHA group tends to con-
sume less oxygen during all recording states, especially in ETS states.
Moreover, the ADP/ATP ratio (Fig. 3) that refers to the energy status
of cells was signiﬁcantly higher in the DHA group and signiﬁcantly
lower in the EGCG group, whereas in the EGCG + DHA group, the
ADP/ATP ratio was similar to that of the control group.
3.2. EGCG reverses the increase of intracellular ROS caused by DHA
treatment
The treatmentwith 25 μMDHA for 4 h signiﬁcantly increased (150%)
the intracellular ROS levels (Fig. 4) compared to the control and EGCG
groups. In contrast, treatment with 25 μM DHA concomitant with
25 μM EGCG attenuated and reversed the increase in ROS levels
induced by DHA.
3.3. DHA downregulates genes related to mitochondrial function,
upregulates MnSod in parallels with Ucps, which maintained upregulation
with EGCG cotreatment
The effects of DHA, EGCG and DHA + EGCG on the mRNA gene ex-
pression of marker enzymes of mitochondrial functionality are shown
in Table 1. As in the respiration analyses, treatment with 25 μM EGCG
did not induce a change in mitochondrial gene expression. In the case
of 25 μM DHA treatment, Cs and ATPase gene expression did not differ
between the groups. In contrast, Cox and Ant1 gene expression were
downregulated compared to the control group; however, Cox and
Ant1 were not downregulated when the cells were treated with DHA
concomitant with EGCG. Both uncoupling protein genes (Ucp2 and
Ucp3) are expressed in muscle cells and were signiﬁcantly upregulated
in the DHA and EGCG+DHA groups. In examining the antioxidant sys-
tem of the mitochondria,MnSod gene expression was signiﬁcantly up-
regulated by DHA treatment compared to the control, but not in the
co-treatment group.
3.4. DHA decreases mitochondrial membrane potential simultaneously
with an increase of intracellular Ca2+ levels
Fig. 5 shows the results for theMMPmeasurements, there was a sig-
niﬁcant increase in arbitrary ﬂuorescence unit (AFU) values for the DHA
treatment with respect to the control conditions, indicating a decrease
in the membrane potential. On the other hand intracellular calcium
was elevated in DHA treatment with the presence of Ca2+ in the
medium (Fig. 6a). This elevation was not produced when a Ca2+-free
solution was used (Fig. 6b).
3.5. DHA and EGCG + DHA increase mtDNA and downregulate enzymes
involved in mitochondrial dynamics
Dynamin-related GTPases mediate the ﬁssion and fusion of
mitochondrial membranes. In the outer membrane, Mfn1and Mfn2,
are involved in the dynamic formation of the mitochondrial network.
Similarly,Opa1, which is in the innermembrane, controlsmitochondrial
membrane fusion, whereas Drp1 and Fiss1 trigger ﬁssion events [28].
The results of how EGCG and/or DHA compounds modulated the
expression of genes implicated in mitochondrial dynamics are shown
in Table 2.
ThemRNA contents of both Fiss1 andDrp1were reduced in response
to DHA and EGCG + DHA compounds, thus DHA treatment seems to
prevent mitochondrial ﬁssion.
Likewise, Mfn2 that takes part in mitochondrial fusion was signiﬁ-
cantly downregulated with the DHA treatment compared to the control
group; however, in terms of Opa1 expression, there were no signiﬁcant
differences between the groups.
Fig. 2. Oxygen consumption of L6 cells under different treatments. Cells were incubated with 25 μM epigallocatechin-3-gallate (EGCG), docosahexaenoic acid (DHA) or EGCG+ DHA for
4 h. In vivo oxygen consumption was then measured using high-resolution respirometry in different intact cell states: A. Routine state, B. Leak state, C. Electron transport system
(ETS) capacity state. D. Oxygen consumption trace in the chamber in the different states: Routine, Leak, ETS and residual oxygen consumption (ROX). The results are expressed as the
mean ± SEM of triplicate measurements and are representative of three independent experiments. Different letters indicate statistical signiﬁcance (p ≤ 0.05).
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gene expression are being downregulated by DHA, as shown in Fig. 7
the relative amount of mtDNA undergoes a signiﬁcant 58% increase in
the DHA-treated cells compared to the control group. Moreover, in the
EGCG + DHA group, there was also an increase of approximately 61%
compared with the control group.
3.6. Mitochondrial morphology after the DHA and EGCG treatments
To investigate whether EGCG and DHA directly alter mitochondrial
dynamics, a morphological analysis was performed using ﬂuorescence
microscopy with the mitochondrial mass marker MitoTracker Green
FM, which provided information about mitochondrial organisation
and dynamics in L6 myocytes. Fig. 8a and e shows that the L6 control
cells exhibited tubular networks with a higher proportion of round
spheres, medium mitochondrial length and stubby mitochondria.
After EGCG treatment (Fig. 8b and e), the mitochondrial morphology
was similar to the control groups, with round spheres and medium
length shapes. In contrast, the mitochondrial morphology after DHA
treatment (Fig. 8c) was shifted toward a fragmented mitochondriaFig. 3. ADP/ATP ratio in L6 cells treatedwith EGCG, DHA or DHA+ EGCG. Cells were incu-
bated with 25 μM epigallocatechin-3-gallate (EGCG), docosahexaenoic acid (DHA) or
EGCG + DHA for 4 h. The ADP/ATP ratio was then measured using an Aposensor kit. The
results are expressed as the mean ± SEM of triplicate measurements and are representa-
tive of three independent experiments. Different letters indicate statistically
signiﬁcant differences (p ≤ 0.05) among the different groups.with a discontinuous network and with a higher proportion of large
and elongated mitochondria. Despite changes in mitochondrial visual
morphology in DHA treatment there was an increase of medium mito-
chondria (Fig. 8e). Co-treatment with EGCG (Fig. 8d) and DHA
reversed the mitochondrial fragmentation, restoring the mitochondrial
network with an increase in elongated mitochondria, and rounder
mitochondria with short and medium lengths (Fig. 8e).
4. Discussion
The beneﬁcial effects of PUFAs against obesity and cardiovascular
diseases have been well described [29,30]. Moreover polyphenols
have also been demonstrated to exhibit a variety of beneﬁcial biological
properties, also including obesity and cardiovascular disease [31,32].
Especially DHA, as a normal component of the human diet could per-
form unusual shapes that could impact packing and hence membrane
structure and properties that affect cellular function including signalling
pathways, that may explain thewide variety of reported health beneﬁts
of n− 3 PUFAs [33]. But it is important to note that their structure withFig. 4. ROS levels in L6 cells treated with EGCG, DHA or EGCG + DHA. Cells were
incubated with 25 μM epigallocatechin-3-gallate (EGCG), docosahexaenoic acid (DHA)
or EGCG + DHA for 4 h. Intracellular reactive oxygen species (ROS) was then measured
using the ﬂuorescent probe 2′,7′-dichloroﬂuorescein-diacetate (DCFH-DA) assay. The
results are expressed as the mean ± SEM of triplicate measurements and are representa-
tive of three independent experiments. Different letters indicate statistically signiﬁcant
differences (p ≤ 0.05) among the different groups.
Table 1
mRNA expression indicatingmitochondrial function in L6 cells treatedwith DHA, EGCG or
DHA + EGCG.
Control EGCG
(25 μM)
DHA
(25 μM)
EGCG + DHA
(25 μM each)
Cox 1.00 ± 0.03a 0.99 ± 0.09ab 0.82 ± 0.03b 0.77 ± 0.08ab
Cs 1.00 ± 0.03a 0.92 ± 0.07a 1.02 ± 0.06a 0.92 ± 0.06a
ATPase 1.00 ± 0.02a 1.04 ± 0.03a 1.01 ± 0.05a 0.85 ± 0.08a
Ant1 1.00 ± 0.02a 0.89 ± 0.07ab 0.86 ± 0.03b 0.89 ± 0.04ab
Ucp3 1.23 ± 0.15a 1.32 ± 0.28a 2.51 ± 0.29b 2.03 ± 0.37b
Ucp2 1.05 ± 0.16a 1.29 ± 0.12a 2.48 ± 0.07b 2.11 ± 0.37b
MnSod 1.00 ± 0.05a 1.21 ± 0.16ab 1.18 ± 0.17b 1.13 ± 0.01ab
Cellswere incubatedwith 25 μMepigallocatechin-3-gallate (EGCG), docosahexaenoic acid
(DHA) or EGCG+DHA for 4 h. Different mRNA levels associatedwith the oxidative phos-
phorylation system (OXPHOS) such as cytochrome c oxidase subunit V (Cox), citrate syn-
thase (Cs), ATP5A1 (ATPase), adenine nucleotide translocase 1 (Ant1), uncoupling protein
3 (Ucp3), uncoupling protein 2 (Ucp2), and manganese superoxide dismutase (MnSod),
were then analysed using real-time qRT-PCR. The results are expressed as the mean ±
SEMof triplicatemeasurements and are representative of three independent experiments.
Different letters indicate statistically signiﬁcant differences (p≤ 0.05) among the different
groups.
Fig. 6. Intracellular calcium levels in L6 cells treated with EGCG, DHA or DHA + EGCG.
Cells were incubated with 25 μM epigallocatechin-3-gallate (EGCG), docosahexaenoic
acid (DHA) or EGCG+DHA for 4 h. Intracellular calcium levelswere thenmeasured in dif-
ferent medium conditions: A. calcium-free medium and B. calcium-replete medium. The
results are expressed as the mean ± SEM of triplicate measurements and are representa-
tive of three independent experiments. Different letters indicate statistically signiﬁcant
differences (p ≤ 0.05) among the different groups.
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authors have reported that DHA-enriched cells are more susceptible to
oxidative insult, resulting in an exacerbation of ROS generation [34]
and depending on the concentrations and conditions used, some re-
sponses could be affected, so it will be useful to protect these cells
with antioxidants [35]. The main objective then is to test if EGCG, a
well-known potent antioxidant, could reverse and avoid cellular oxida-
tive damage related to DHA.
In aerobic organisms, approximately 85–90% of cellular oxygen is
consumed bymitochondria to produce energy in the form of ATPmole-
cules, concomitant with the formation of ROS. ROS induce chemical
modiﬁcations in othermolecules, generating oxidative damage, regulat-
ing signal transduction components, and acting as second messengers
for various physiological and pathological stimuli [36]. We wanted to
study the effects of DHA and EGCG at the level ofmitochondrial dynam-
ics and bioenergetics in muscle cells. Results suggest that although the
DHA compound is not toxic to the cells, this compound leads to altered
mitochondrial dynamics, with subsequent changes in mitochondrial
function, including alteration in respiration and ROS generation.
The results from the in vivo oxygen consumption assay indicate that
substrate oxidationwas decreased in the Routine and Leak states, by the
DHA and EGCG+DHA treatments. In addition, DHA-treated cells clear-
ly consumed less oxygen during the entire recording protocol. A few
studies have used dietary ﬁsh oil to investigate the inﬂuence ofFig. 5. Mitochondrial membrane potential in L6 cells treated with EGCG, DHA
or DHA + EGCG. Cells were incubated with 25 μM epigallocatechin-3-gallate
(EGCG), docosahexaenoic acid (DHA) or EGCG + DHA for 4 h. The mitochondrial
membrane potential (MMP) was then measured by the addition of oligomycin
to inhibit ATP production and subsequently with, carbonyl cyanide 4-(triﬂuoromethoxy)
phenylhydrazone (FCCP) to achieve to the maximal membrane depolarization. The results
are expressed as % of arbitrary ﬂuorescence unit (AFU) increase with respect to basal con-
ditions, compared to control treatment. Results are expressed as the mean ± SEM of trip-
licate measurements and are representative of three independent experiments. Different
letters indicate statistically signiﬁcant differences (p ≤ 0.05) among the different groups.
Arbitrary ﬂuorescence units (AFU).omega-3 PUFAs on mitochondrial respiration and have reported either
no change or decreases during some measurements of various sub-
strates [19,37]. Here, with the decrease in mitochondrial respiration,
mitochondrial functionality was also affected. DHAmay have contribut-
ed as a potent deregulator of O2 consumption and oxidative phosphor-
ylation with the decreasing bioenergetic activities being, in part, due to
the result of membrane perturbations caused by DHA [19].
The incubation of L6 myocytes with 25 μM DHA for 4 h led to an in-
crease (150%) in intracellular ROS production without causing loss of
cell viability. This result is in agreementwith the interaction or incorpo-
ration of added DHA into the cell membrane phospholipid composition
[38,39] and the susceptibility of most omega-3 PUFAs to produce oxida-
tive damage in cells [40]. In addition, many lipid peroxidation products
are themselves very potent ROS producers that can induce considerable
damage to other biological molecules [37]. However oxidative stress
from ROS could be a cause and a consequence of the observed mito-
chondrial alteration and addresses the possibility that ROS precede
DHA changes in mitochondrial dysfunction. The increased ROS levels
in the DHA group led toMnSod overexpression, which is one of the pri-
mary antioxidant responses to elevated ROS production [41,42] a part
from the Ucp3 overexpression during DHA treatment that might alsoTable 2
mRNA expression for mitochondrial dynamics in L6 cells treated with DHA, EGCG or
DHA + EGCG.
Control EGCG
(25 μM)
DHA
(25 μM)
EGCG + DHA
(25 μM each)
Fiss1 1.00 ± 0.01a 0.96 ± 0.04a 0.67 ± 0.04b 0.71 ± 0.04b
Drp1 1.00 ± 0.03a 0.90 ± 0.05ab 0.77 ± 0.0b 0.72 ± 0.02b
Mfn2 1.00 ± 0.03a 0.92 ± 0.01a 0.76 ± 0.01b 0.85 ± 0.05ab
Opa1 1.01 ± 0.05a 1.05 ± 0.05a 0.93 ± 0.08a 0.90 ± 0.04a
Cells were incubated with 25 μM epigallocatechin-3-gallate (EGCG), docosahexaenoic acid
(DHA) or EGCG+DHA for 4 h to analyse using real-time qRT-PCR differentmRNA levels as-
sociated with the mitochondrial dynamics system, such as mitochondrial ﬁssion 1
protein (Fiss1), dynamin related protein 1 (Drp1), mitofusin 2 (Mfn2), and optic atrophy 1
(Opa1). The results are expressed as the mean ± SEM of triplicate measurements and are
representative of three independent experiments. Different letters indicate statistically sig-
niﬁcant differences (p ≤ 0.05) among the different groups.
Fig. 7. mtDNA/nDNA of L6 cells treated with EGCG, DHA or EGCG+ DHA. Cells were
incubated with 25 μM epigallocatechin-3-gallate (EGCG), docosahexaenoic acid (DHA)
or EGCG + DHA for 4 h. mtDNA/nDNA ratio was expressed as the Nd3/GAPDH ratio by
real time PCR. NADH-dehydrogenase subunit 3 (Nd3) as mitochondrial DNA and
glyceraldehydes-3-phosphate dehydrogenase (Gapdh) as nuclear DNA. The results are
expressed as the mean ± SEM of triplicate measurements and are representative of
three independent experiments. Different letters indicate statistically signiﬁcant
differences (p ≤ 0.05) among the different groups.
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under oxidative stress conditions [43].Moreover theDHAcell treatment
increased ADP/ATP ratio with a downregulation of Ant1 geneFig. 8.Mitochondrialmorphology of L6 cells treatedwith EGCG,DHA or DHA+ EGCG. Cellswer
EGCG + DHA for 4 h. The mitochondrial network and morphology were visualised using Mito
25 μM and D. EGCG + DHA (25 μM each). E. Mitochondria morphology quantiﬁcation (%). Fo
and grouped into three categories as follows: short type (1 μm ≤ in length), medium rod type
a percentage of the total number of mitochondria counted per treatment.expression, which blocked the exchange of ADP and ATP across the mi-
tochondrial inner membrane and disrupted the energy homeostasis,
concomitant with lowered mitochondrial functionality through ETC
and oxidative phosphorylation (OXPHOS) system disruptions, with
Cox gene downregulation and the decrease of the oxygen consumption
with low respiratory capacitywith the incapacity to increase respiration
upon the addition of FCCP shown in the DHA treatment, as other au-
thors have reported [44–46]. The impairment in mitochondrial func-
tionality was reversed in the EGCG + DHA group, whereas the ROS
levels remained at the same levels as the control cells, which is consis-
tent with the role of EGCG as a potent antioxidant [47] and as an
uncoupler-like [48] compound, decreasing ROS production. The poly-
phenol structure of EGCG facilitates its capacity to penetrate mem-
branes, resulting in ROS scavenging between the mitochondrial
membrane and matrix [49]. It is important to emphasise that the over-
expression of Ucp2 andUcp3wasmaintained in the DHA+EGCG group
because, despite the antioxidant effects of EGCG, DHA was still present
in the culture media.
Furthermore, mitochondria also participate in intracellular Ca2+ ho-
meostasis via several Ca2+ uptake and release pathways, and ROS pro-
duction could affect Ca2+ homeostasis due to the deterioration of
membranes that contain the intracellular Ca2+ stores [50,51]. Thee incubatedwith 25 μMepigallocatechin-3-gallate (EGCG), docosahexaenoic acid (DHA) or
Tracker Green FM staining and a confocal microscope. A. Control, B. EGCG 25 μM, C. DHA
r the quantiﬁcation of mitochondrial morphology, mitochondrial length was measured
(1–2 μm in length) and long type (N2 μm) using Image J software. Results are shown as
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displayed higher intracellular Ca2+ levels when Ca2+ was supplement-
ed in the culture media. Accordingly, it appears that the high levels of
ROS produced by DHA membrane incorporation or through alterations
of the cell membrane phospholipid composition induced a calcium in-
ﬂux of external calcium that was not from mitochondria or other calci-
um stores.
Mitochondrial metabolic changes could be produced by the varia-
tion in membrane fatty acid composition that is linked with the
respiratory activity and OXPHOS functionality, so the downregulation
of ﬁssion (Fiss1, Drp1) and fusion (Mfn2) gene expression during DHA
treatment is a mechanism to compensate mitochondrial function and
to restore mitochondrial tubules [8] maintaining freedom for both
fusion and ﬁssion that is a fundamental factor to ensure adequate
bioenergetics utility of the mitochondria.
Another compensatorymechanism is the highermtDNA/nDNA ratio
of the DHA-treated cells, suggesting that endogenous and exogenous
oxidative stresses are factors involved in the increase of the mitochon-
drial abundance and mtDNA copy number in human and animal cells
[3], resulting from a feedback response that compensates for defective
mitochondria, hallmarks of an impaired respiratory chain or mutated
mtDNA [52]. The Fiss1 and Drp1 gene expression were also downregu-
lated with more rounded and elongated, short and medium length
mitochondria developing functional machineries and restoring mito-
chondrial tubules [4,53,54] in the EGCG + DHA group. This inhibition
of ﬁssion events could also repair mitochondrial damage that allows
the mixing of mtDNA from other mitochondria becoming more
elongated. Moreover endogenous respiration in the Routine state was
also low concomitantly with altered mitochondrial morphology and
cellular bioenergetic dynamics as other authors had reported [55–57],
and similar to the DHA group, due to the PUFA-containingmitochondri-
al membranes [46] which leads to oxidative damage. In addition, it has
previously been demonstrated that Drp1 downregulation in HeLa
cells leads to slower cell growth, ETC uncoupling, decreased cellular
respiration and increased ROS levels [55], as what occurred here in L6
myocytes after DHA treatment. Mitochondrial morphology images re-
veal that in DHA treatment the majority of the mitochondria were
large, elongated with some fragmented compared to control cells, as
described in 3T3-L1 adipocyte studies [58,59] and could be caused by
the downregulation of Fiss1 and Drp1 gene expression as described in
rat skeletal muscle studies [60]. In addition, this deregulated mitochon-
drialmorphologymight lead to alterations in oxidative phosphorylation
[8,61] as we had been shown in cells treated with DHA, although the
imbalance in mitochondrial architecture in this situation revealed that
mitochondria are able to adjust their own metabolism, to keep the cell
alive; that is what we call adaptive response to understand mitochon-
drial physiology. The data presented ﬁt our hypothesis indicating that
the antioxidant and uncoupling abilities of EGCG mentioned above,
inﬂuence mitochondrial morphology, reduce DHA intracellular ROS
overproduction, and alter the ADP/ATP ratio and expression of Cox
and Ant1 genes to control levels.
In conclusion, the combination of DHA + EGCG could be a good
choice for avoiding and correcting the possible deleterious effects of
DHA.
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